Listed in the December 27, 2023 extract; not in the current extract (September 22, 2026): Ran-Fentanyl Matrix Patch (02330105), Co Fentanyl Matrix Patch (02386844). Source: odb-formulary-ed43-extract-2023-12-27.xml; compared with odb-formulary-ed43-extract-2026-09-22.xml.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Fentanyl transdermal system
8 Limited Use · 14 not a benefit
Sandoz Fentanyl Patch · DIN 02327112 · 12 mcg/hr · Trans Patch
Limited Use, Reason for Use code 511 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 511 required
Write on scriptReason for Use code 511 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Sandoz Fentanyl Patch · DIN 02327112
Manufacturer: Sandoz Canada Inc.; listing date 2010-03-02
Health Canada: Marketed since 2010-11-01 · brand SANDOZ FENTANYL PATCH · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 12 MCG/HOUR · company Sandoz canada incorporated · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordSandoz Fentanyl Patch: Formulary list price $3.32 per unit (the source does not state the unit; exact figure $3.3200). What the ministry pays, not the patient.
Ministry pays: $3.3200 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02327112)
Source record
DIN 02327112: Sandoz Fentanyl Patch
Raw flags: sec12=Y, sec3=Y
Item: 280808169; group id 402; item number 0961; lccId 00402; manufacturer id SDZ
Source form: Trans Patch; strength: 12mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.3200; ministry $3.3200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02327112
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81243
Interchangeable products
Duragesic 12 · DIN 02280345 · not recorded
Teva-Fentanyl · DIN 02311925 · $3.3200
Shortage status: resolved shortage (ended April 14, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02327112
Shortage record checked October 6, 2026
Teva-Fentanyl · DIN 02311925 · 12 mcg/hr · Trans Patch
Limited Use, Reason for Use code 511 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 511 required
Write on scriptReason for Use code 511 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Teva-Fentanyl · DIN 02311925
Manufacturer: Teva Canada Limited; listing date 2008-12-23
Health Canada: Marketed since 2012-12-21 · brand TEVA-FENTANYL · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 12 MCG/HOUR · company Teva canada limited · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Fentanyl: Formulary list price $3.32 per unit (the source does not state the unit; exact figure $3.3200). What the ministry pays, not the patient.
Ministry pays: $3.3200 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02311925)
Source record
DIN 02311925: Teva-Fentanyl
Raw flags: sec12=Y, sec3=Y
Item: 280808169; group id 402; item number 0961; lccId 00402; manufacturer id TEV
Source form: Trans Patch; strength: 12mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.3200; ministry $3.3200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02311925
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79746
Interchangeable products
Duragesic 12 · DIN 02280345 · not recorded
Sandoz Fentanyl Patch · DIN 02327112 · $3.3200
Shortage status: resolved shortage (ended May 8, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02311925
Shortage record checked October 6, 2026
Sandoz Fentanyl Patch · DIN 02327120 · 25 mcg/hr · Trans Patch
Limited Use, Reason for Use code 511 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 511 required
Write on scriptReason for Use code 511 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Sandoz Fentanyl Patch · DIN 02327120
Manufacturer: Sandoz Canada Inc.; listing date 2010-03-02
Health Canada: Marketed since 2010-11-01 · brand SANDOZ FENTANYL PATCH · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 25 MCG/HOUR · company Sandoz canada incorporated · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordSandoz Fentanyl Patch: Formulary list price $8.56 per unit (the source does not state the unit; exact figure $8.5600). What the ministry pays, not the patient.
Ministry pays: $8.5600 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02327120)
Source record
DIN 02327120: Sandoz Fentanyl Patch
Raw flags: sec12=Y, sec3=Y
Item: 280808079; group id 404; item number 0963; lccId 00067; manufacturer id SDZ
Source form: Trans Patch; strength: 25mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $8.5600; ministry $8.5600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02327120
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81244
Interchangeable products
Duragesic · DIN 02275813 · not recorded
Duragesic 25 · DIN 01937383 · not recorded
Teva-Fentanyl · DIN 02282941 · $8.5600
Shortage status: resolved shortage (ended February 1, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02327120
Shortage record checked October 6, 2026
Teva-Fentanyl · DIN 02282941 · 25 mcg/hr · Trans Patch
Limited Use, Reason for Use code 511 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 511 required
Write on scriptReason for Use code 511 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Teva-Fentanyl · DIN 02282941
Manufacturer: Teva Canada Limited; listing date 2007-01-02
Health Canada: Marketed since 2012-12-21 · brand TEVA-FENTANYL · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 25 MCG/HOUR · company Teva canada limited · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Fentanyl: Formulary list price $8.56 per unit (the source does not state the unit; exact figure $8.5600). What the ministry pays, not the patient.
Ministry pays: $8.5600 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02282941)
Source record
DIN 02282941: Teva-Fentanyl
Raw flags: sec12=Y, sec3=Y
Item: 280808079; group id 404; item number 0963; lccId 00067; manufacturer id TEV
Source form: Trans Patch; strength: 25mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $8.5600; ministry $8.5600
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02282941
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76857
Interchangeable products
Duragesic · DIN 02275813 · not recorded
Duragesic 25 · DIN 01937383 · not recorded
Sandoz Fentanyl Patch · DIN 02327120 · $8.5600
Shortage status: resolved shortage (ended May 29, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02282941
Shortage record checked October 6, 2026
Sandoz Fentanyl Patch · DIN 02327147 · 50 mcg/hr · Trans Patch
Limited Use, Reason for Use code 511 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 511 required
Write on scriptReason for Use code 511 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Sandoz Fentanyl Patch · DIN 02327147
Manufacturer: Sandoz Canada Inc.; listing date 2010-03-02
Health Canada: Marketed since 2010-11-01 · brand SANDOZ FENTANYL PATCH · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 50 MCG/HOUR · company Sandoz canada incorporated · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordSandoz Fentanyl Patch: Formulary list price $16.11 per unit (the source does not state the unit; exact figure $16.1100). What the ministry pays, not the patient.
Ministry pays: $16.1100 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02327147)
Source record
DIN 02327147: Sandoz Fentanyl Patch
Raw flags: sec12=Y, sec3=Y
Item: 280808080; group id 404; item number 0964; lccId 00067; manufacturer id SDZ
Source form: Trans Patch; strength: 50mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $16.1100; ministry $16.1100
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02327147
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81246
Interchangeable products
Duragesic · DIN 02275821 · not recorded
Duragesic 50 · DIN 01937391 · not recorded
Teva-Fentanyl · DIN 02282968 · $16.1100
Shortage status: resolved shortage (ended January 31, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02327147
Shortage record checked October 6, 2026
Teva-Fentanyl · DIN 02282968 · 50 mcg/hr · Trans Patch
Limited Use, Reason for Use code 511 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 511 required
Write on scriptReason for Use code 511 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Teva-Fentanyl · DIN 02282968
Manufacturer: Teva Canada Limited; listing date 2007-01-02
Health Canada: Marketed since 2012-12-21 · brand TEVA-FENTANYL · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 50 MCG/HOUR · company Teva canada limited · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordTeva-Fentanyl: Formulary list price $16.11 per unit (the source does not state the unit; exact figure $16.1100). What the ministry pays, not the patient.
Ministry pays: $16.1100 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02282968)
Source record
DIN 02282968: Teva-Fentanyl
Raw flags: sec12=Y, sec3=Y
Item: 280808080; group id 404; item number 0964; lccId 00067; manufacturer id TEV
Source form: Trans Patch; strength: 50mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $16.1100; ministry $16.1100
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02282968
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76858
Interchangeable products
Duragesic · DIN 02275821 · not recorded
Duragesic 50 · DIN 01937391 · not recorded
Sandoz Fentanyl Patch · DIN 02327147 · $16.1100
Shortage status: resolved shortage (ended May 13, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02282968
Shortage record checked October 6, 2026
Sandoz Fentanyl Patch · DIN 02327155 · 75 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Sandoz Fentanyl Patch · DIN 02327155
Manufacturer: Sandoz Canada Inc.; listing date 2010-03-02
Health Canada: Marketed since 2010-11-01 · brand SANDOZ FENTANYL PATCH · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 75 MCG/HOUR · company Sandoz canada incorporated · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordFormulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02327155)
Source record
DIN 02327155: Sandoz Fentanyl Patch
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808081; group id 405; item number 0965; lccId None; manufacturer id SDZ
Source form: Trans Patch; strength: 75mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $22.6500; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02327155
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81247
Interchangeable products
Duragesic · DIN 02275848 · not recorded
Duragesic 75 · DIN 01937405 · not recorded
Teva-Fentanyl · DIN 02282976 · not recorded
Shortage status: resolved shortage (ended January 11, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02327155
Shortage record checked October 6, 2026
Teva-Fentanyl · DIN 02282976 · 75 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Teva-Fentanyl · DIN 02282976
Manufacturer: Teva Canada Limited; listing date 2007-01-02
Health Canada: Marketed since 2012-12-21 · brand TEVA-FENTANYL · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 75 MCG/HOUR · company Teva canada limited · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordFormulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02282976)
Source record
DIN 02282976: Teva-Fentanyl
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808081; group id 405; item number 0965; lccId None; manufacturer id TEV
Source form: Trans Patch; strength: 75mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $22.6500; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02282976
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76859
Interchangeable products
Duragesic · DIN 02275848 · not recorded
Duragesic 75 · DIN 01937405 · not recorded
Sandoz Fentanyl Patch · DIN 02327155 · not recorded
Shortage status: resolved shortage (ended May 13, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02282976
Shortage record checked October 6, 2026
Sandoz Fentanyl Patch · DIN 02327163 · 100 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Sandoz Fentanyl Patch · DIN 02327163
Manufacturer: Sandoz Canada Inc.; listing date 2010-03-02
Health Canada: Marketed since 2010-11-01 · brand SANDOZ FENTANYL PATCH · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 100 MCG/HOUR · company Sandoz canada incorporated · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordFormulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02327163)
Source record
DIN 02327163: Sandoz Fentanyl Patch
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808082; group id 405; item number 0966; lccId None; manufacturer id SDZ
Source form: Trans Patch; strength: 100mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $28.1950; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02327163
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81248
Interchangeable products
Duragesic · DIN 02275856 · not recorded
Duragesic 100 · DIN 01937413 · not recorded
Teva-Fentanyl · DIN 02282984 · not recorded
Shortage status: resolved shortage (ended January 4, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02327163
Shortage record checked October 6, 2026
Teva-Fentanyl · DIN 02282984 · 100 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefitMarketed · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Teva-Fentanyl · DIN 02282984
Manufacturer: Teva Canada Limited; listing date 2007-01-02
Health Canada: Marketed since 2012-12-21 · brand TEVA-FENTANYL · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 100 MCG/HOUR · company Teva canada limited · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordFormulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02282984)
Source record
DIN 02282984: Teva-Fentanyl
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808082; group id 405; item number 0966; lccId None; manufacturer id TEV
Source form: Trans Patch; strength: 100mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): $28.1950; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02282984
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76860
Interchangeable products
Duragesic · DIN 02275856 · not recorded
Duragesic 100 · DIN 01937413 · not recorded
Sandoz Fentanyl Patch · DIN 02327163 · not recorded
Shortage status: resolved shortage (ended June 16, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02282984
Shortage record checked October 6, 2026
Sandoz Fentanyl Patch · PIN 09858348 · 12 mcg/hr · Trans Patch
Limited Use, Reason for Use code 689 requiredOntario PIN; no Health Canada record under this code
StatusLimited Use, Reason for Use code 689 required
Write on scriptReason for Use code 689 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Check Health Canada brand searchOntario Limited Use criteria, code 689
Reason for Use code 689
For the treatment of chronic pain in patients who have been stabilized on fentanyl and require the use of fentanyl 12mcg/hr patches for dose adjustment up or down to the lowest optimal opioid dose.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Sandoz Fentanyl Patch · DIN 09858348
Manufacturer: Sandoz Canada Inc.; listing date 2024-09-27
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)Sandoz Fentanyl Patch: Formulary list price $3.32 per unit (the source does not state the unit; exact figure $3.3200). What the ministry pays, not the patient.
Ministry pays: $3.3200 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858348)
Source record
DIN 09858348: Sandoz Fentanyl Patch
Raw flags: sec12=Y, sec3=Y
Item: 280808469; group id 403; item number 0962; lccId 00403; manufacturer id SDZ
Source form: Trans Patch; strength: 12mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.3200; ministry $3.3200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858348
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Interchangeable products
Duragesic 12 · DIN 09858350 · not recorded
Teva-Fentanyl · DIN 09858349 · $3.3200
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09858348
Shortage record checked October 6, 2026
Teva-Fentanyl · PIN 09858349 · 12 mcg/hr · Trans Patch
Limited Use, Reason for Use code 689 requiredOntario PIN; no Health Canada record under this code
StatusLimited Use, Reason for Use code 689 required
Write on scriptReason for Use code 689 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Check Health Canada brand searchOntario Limited Use criteria, code 689
Reason for Use code 689
For the treatment of chronic pain in patients who have been stabilized on fentanyl and require the use of fentanyl 12mcg/hr patches for dose adjustment up or down to the lowest optimal opioid dose.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Teva-Fentanyl · DIN 09858349
Manufacturer: Teva Canada Limited; listing date 2024-09-27
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)Teva-Fentanyl: Formulary list price $3.32 per unit (the source does not state the unit; exact figure $3.3200). What the ministry pays, not the patient.
Ministry pays: $3.3200 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858349)
Source record
DIN 09858349: Teva-Fentanyl
Raw flags: sec12=Y, sec3=Y
Item: 280808469; group id 403; item number 0962; lccId 00403; manufacturer id TEV
Source form: Trans Patch; strength: 12mcg/hr
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $3.3200; ministry $3.3200
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858349
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Interchangeable products
Duragesic 12 · DIN 09858350 · not recorded
Sandoz Fentanyl Patch · DIN 09858348 · $3.3200
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09858349
Shortage record checked October 6, 2026
Duragesic 12 · PIN 09858350 · 12 mcg/hr · Trans Patch
Listed, not a benefitOntario PIN; no Health Canada record under this code
StatusListed, not a benefit
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Check Health Canada brand searchOntario Limited Use criteria, code 689
Reason for Use code 689
For the treatment of chronic pain in patients who have been stabilized on fentanyl and require the use of fentanyl 12mcg/hr patches for dose adjustment up or down to the lowest optimal opioid dose.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Duragesic 12 · DIN 09858350
Manufacturer: Janssen-Ortho Inc.; listing date 2024-09-27
No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN.
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)Duragesic 12: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858350)
Source record
DIN 09858350: Duragesic 12
Raw flags: notABenefit=Y, sec3=Y
Item: 280808469; group id 403; item number 0962; lccId 00403; manufacturer id JNO
Source form: Trans Patch; strength: 12mcg/hr
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858350
Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Interchangeable products
Sandoz Fentanyl Patch · DIN 09858348 · $3.3200
Teva-Fentanyl · DIN 09858349 · $3.3200
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=09858350
Shortage record checked October 6, 2026
Duragesic 12 · DIN 02280345 · 12 mcg/hr · Trans Patch
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.Discontinued November 24, 2009 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Duragesic 12 · DIN 02280345
Manufacturer: Janssen-Ortho Inc.; listing date 2008-12-23
Health Canada: Cancelled post market since 2009-11-24 · brand DURAGESIC 12 · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 12 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic 12: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02280345)
Source record
DIN 02280345: Duragesic 12
Raw flags: notABenefit=Y, sec3=Y
Item: 280808169; group id 402; item number 0961; lccId 00402; manufacturer id JNO
Source form: Trans Patch; strength: 12mcg/hr
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02280345
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76602
Interchangeable products
Sandoz Fentanyl Patch · DIN 02327112 · $3.3200
Teva-Fentanyl · DIN 02311925 · $3.3200
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02280345
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since November 24, 2009 — choose a marketed DIN from the same-category list.
Duragesic · DIN 02275813 · 25 mcg/hr · Trans Patch
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.Discontinued October 31, 2018 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Duragesic · DIN 02275813
Manufacturer: Janssen Inc.; listing date 2010-04-23
Health Canada: Cancelled post market since 2018-10-31 · brand DURAGESIC · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 25 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02275813)
Source record
DIN 02275813: Duragesic
Raw flags: notABenefit=Y, sec3=Y
Item: 280808079; group id 404; item number 0963; lccId 00067; manufacturer id JAN
Source form: Trans Patch; strength: 25mcg/hr
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02275813
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76148
Interchangeable products
Duragesic 25 · DIN 01937383 · not recorded
Sandoz Fentanyl Patch · DIN 02327120 · $8.5600
Teva-Fentanyl · DIN 02282941 · $8.5600
Shortage status: discontinued (November 1, 2018, reported by JANSSEN INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02275813
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 31, 2018 — choose a marketed DIN from the same-category list.
Duragesic 25 · DIN 01937383 · 25 mcg/hr · Trans Patch
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.Discontinued November 24, 2009 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Duragesic 25 · DIN 01937383
Manufacturer: Janssen-Ortho Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2009-11-24 · brand DURAGESIC 25 · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 25 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic 25: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01937383)
Source record
DIN 01937383: Duragesic 25
Raw flags: notABenefit=Y, sec3=Y
Item: 280808079; group id 404; item number 0963; lccId 00067; manufacturer id JNO
Source form: Trans Patch; strength: 25mcg/hr
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01937383
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12656
Interchangeable products
Duragesic · DIN 02275813 · not recorded
Sandoz Fentanyl Patch · DIN 02327120 · $8.5600
Teva-Fentanyl · DIN 02282941 · $8.5600
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01937383
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since November 24, 2009 — choose a marketed DIN from the same-category list.
Duragesic · DIN 02275821 · 50 mcg/hr · Trans Patch
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.Discontinued October 31, 2018 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Duragesic · DIN 02275821
Manufacturer: Janssen Inc.; listing date 2010-04-23
Health Canada: Cancelled post market since 2018-10-31 · brand DURAGESIC · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 50 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02275821)
Source record
DIN 02275821: Duragesic
Raw flags: notABenefit=Y, sec3=Y
Item: 280808080; group id 404; item number 0964; lccId 00067; manufacturer id JAN
Source form: Trans Patch; strength: 50mcg/hr
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02275821
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76149
Interchangeable products
Duragesic 50 · DIN 01937391 · not recorded
Sandoz Fentanyl Patch · DIN 02327147 · $16.1100
Teva-Fentanyl · DIN 02282968 · $16.1100
Shortage status: discontinued (November 1, 2018, reported by JANSSEN INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02275821
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 31, 2018 — choose a marketed DIN from the same-category list.
Duragesic 50 · DIN 01937391 · 50 mcg/hr · Trans Patch
Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.Discontinued November 24, 2009 · checked October 5, 2026
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Ontario Limited Use criteria, code 511
Reason for Use code 511
For the treatment of chronic pain in patients who cannot tolerate, or have failed treatment with a long-acting opioid. Intolerance or failed treatment with a long-acting opioid will be subject to verification at the time of dispensing.
Coverage limit:
LU Authorization Period: 1 year
1 brand, same coverage
Duragesic 50 · DIN 01937391
Manufacturer: Janssen-Ortho Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2009-11-24 · brand DURAGESIC 50 · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 50 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic 50: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01937391)
Source record
DIN 01937391: Duragesic 50
Raw flags: notABenefit=Y, sec3=Y
Item: 280808080; group id 404; item number 0964; lccId 00067; manufacturer id JNO
Source form: Trans Patch; strength: 50mcg/hr
Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01937391
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12657
Interchangeable products
Duragesic · DIN 02275821 · not recorded
Sandoz Fentanyl Patch · DIN 02327147 · $16.1100
Teva-Fentanyl · DIN 02282968 · $16.1100
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01937391
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since November 24, 2009 — choose a marketed DIN from the same-category list.
Duragesic · DIN 02275848 · 75 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.Discontinued October 31, 2018 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Duragesic · DIN 02275848
Manufacturer: Janssen Inc.; listing date 2010-04-23
Health Canada: Cancelled post market since 2018-10-31 · brand DURAGESIC · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 75 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02275848)
Source record
DIN 02275848: Duragesic
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808081; group id 405; item number 0965; lccId None; manufacturer id JAN
Source form: Trans Patch; strength: 75mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02275848
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76150
Interchangeable products
Duragesic 75 · DIN 01937405 · not recorded
Sandoz Fentanyl Patch · DIN 02327155 · not recorded
Teva-Fentanyl · DIN 02282976 · not recorded
Shortage status: discontinued (November 1, 2018, reported by JANSSEN INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02275848
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 31, 2018 — choose a marketed DIN from the same-category list.
Duragesic 75 · DIN 01937405 · 75 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.Discontinued November 24, 2009 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Duragesic 75 · DIN 01937405
Manufacturer: Janssen-Ortho Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2009-11-24 · brand DURAGESIC 75 · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 75 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic 75: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01937405)
Source record
DIN 01937405: Duragesic 75
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808081; group id 405; item number 0965; lccId None; manufacturer id JNO
Source form: Trans Patch; strength: 75mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01937405
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12658
Interchangeable products
Duragesic · DIN 02275848 · not recorded
Sandoz Fentanyl Patch · DIN 02327155 · not recorded
Teva-Fentanyl · DIN 02282976 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01937405
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since November 24, 2009 — choose a marketed DIN from the same-category list.
Duragesic · DIN 02275856 · 100 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.Discontinued October 31, 2018 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; this DIN is on the ministry's EAP drug list (August 2026): submit an Exceptional Access request through SADIE with the clinical rationale; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2018-10-31 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Duragesic · DIN 02275856
Manufacturer: Janssen Inc.; listing date 2010-04-23
Health Canada: Cancelled post market since 2018-10-31 · brand DURAGESIC · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 100 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02275856)
Source record
DIN 02275856: Duragesic
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808082; group id 405; item number 0966; lccId None; manufacturer id JAN
Source form: Trans Patch; strength: 100mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02275856
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=76151
Interchangeable products
Duragesic 100 · DIN 01937413 · not recorded
Sandoz Fentanyl Patch · DIN 02327163 · not recorded
Teva-Fentanyl · DIN 02282984 · not recorded
Shortage status: discontinued (November 1, 2018, reported by JANSSEN INC); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02275856
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since October 31, 2018 — choose a marketed DIN from the same-category list.
Duragesic 100 · DIN 01937413 · 100 mcg/hr · Trans Patch
Off-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.Discontinued November 24, 2009 · checked October 5, 2026
StatusOff-Formulary Interchangeable, not an ODB benefit; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Write on scriptnot an ODB benefit; the ministry's EAP drug list (August 2026) names this generic but not this DIN: confirm the product with the pharmacy or ministry before an Exceptional Access request; no criteria matched in the held records; confirm the applicable criteria through SADIE or the ministry; Health Canada lists this DIN as Cancelled post market since 2009-11-24 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
1 brand, same coverage
Duragesic 100 · DIN 01937413
Manufacturer: Janssen-Ortho Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2009-11-24 · brand DURAGESIC 100 · ATC N02AB03 FENTANYL · form Patch · route Transdermal · ingredients FENTANYL 100 MCG/HOUR · company Janssen inc · schedule Narcotics (cdsa i)
Re-check Health Canada status and shortages (live) · Health Canada product recordDuragesic 100: Formulary list price None per unit (the source does not state the unit; exact figure not recorded). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01937413)
Source record
DIN 01937413: Duragesic 100
Raw flags: notABenefit=Y, sec3=Y, sec3b=Y
Item: 280808082; group id 405; item number 0966; lccId None; manufacturer id JNO
Source form: Trans Patch; strength: 100mcg/hr
Recorded listing: Off-Formulary Interchangeable, not an ODB benefit
Source prices (unrounded): not recorded; ministry not recorded
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01937413
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12659
Interchangeable products
Duragesic · DIN 02275856 · not recorded
Sandoz Fentanyl Patch · DIN 02327163 · not recorded
Teva-Fentanyl · DIN 02282984 · not recorded
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=01937413
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since November 24, 2009 — choose a marketed DIN from the same-category list.
Other products in the same Health Canada class (N02A): coverage varies; not interchangeable
- Acetaminophen + caffeine + codeine (Teva-Lenoltec No.2): general benefit, not a benefit
- Acetaminophen + codeine (PMS-Acetaminophen With Codeine): general benefit, not a benefit
- Hydromorphone (Hydromorph Contin): general benefit, not a benefit
- Morphine (M-Eslon): general benefit, not a benefit
- Acetaminophen + oxycodone (Teva-Oxycocet): general benefit, not a benefit
- Acetylsalicylic acid + oxycodone (Ratio-Oxycodan): general benefit, not a benefit
4 more in the class list below
Other drugs in the same formulary class (28:08:08 Opiate Agonists) and how they are covered
Matched class: 28:08:08 Opiate Agonists
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Some products covered without a code (check the product listing): ACETAMINOPHEN & CAFFEINE & CODEINE PHOSPHATE, ACETAMINOPHEN & CODEINE PHOSPHATE, CODEINE PHOSPHATE, HYDROMORPHONE HCL, METHADONE HCL, MORPHINE SULFATE, OXYCODONE HCL & ACETAMINOPHEN, OXYCODONE HCL & ACETYLSALICYLIC ACID
28:08:08 Opiate Agonists
· 4 products · General benefit (2), Listed, not a benefit (2) · strengths: 300mg & 15mg & 15mg, 300mg & 15mg & 30mg · Tab
· 6 products · General benefit (3), Listed, not a benefit (3) · strengths: 160mg & 8mg/5mL, 300mg & 30mg, 300mg & 60mg · O/L, Tab
· 28 products · General benefit (21), Listed, not a benefit (3), General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (4) · strengths: 4.5mg, 9mg, 3mg, 6mg, 12mg, 18mg, 2mg/mL, 10mg/mL, 1mg/mL, 1mg, 2mg, 4mg, 8mg · CR Cap, Inj Sol-1mL Pk, Oral Sol, Tab
· 35 products · General benefit (31), Listed, not a benefit (1), Off-Formulary Interchangeable, not an ODB benefit (3) · strengths: 10mg, 15mg, 30mg, 60mg, 100mg, 2mg/mL, 10mg/mL, 15mg/mL, 50mg/mL, 20mg, 50mg, 200mg, 5mg · ER Cap, Inj Sol Amp, Inj Sol-1mL Pk, SR Cap, SR Tab, Tab
· 5 products · General benefit (4), Listed, not a benefit (1) · strengths: 5mg & 325mg · Tab
· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: 5mg & 325mg · Tab
· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 330mg & 50mg & 40mg & 15mg, 330mg & 50mg & 40mg & 30mg · Cap
· 9 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 5mg, 10mg, 20mg · Tab
· 13 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 100mg, 200mg, 300mg, 50mg · ER Tab, Tab
· 12 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 37.5mg & 325mg · Tab
· 3 products · General benefit (2), Listed, not a benefit (1) · strengths: 15mg, 30mg · Tab
· 16 products · General benefit (8), Off-Formulary Interchangeable, not an ODB benefit (8) · strengths: 10mg/mL, 1mg, 5mg, 10mg, 25mg · Oral Concentrate, Oral Concentrate (Cherry Flavour), Oral Concentrate (Unflavoured), Tab
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 28:08:08
and 2 more
Full class listing
Related classes: 28:08:04 Nonsteroidal Anti-Inflammatory Agents, 28:08:12 Opiate Partial Agonists, 28:08:92 Miscellaneous Analgesics and Antipyretics, 28:16:04 Antidepressants, 28:16:08 Tranquilizers, 28:16:12 Other Psychotropics, 28:36:08 Anticholinergic Agents, 28:36:20 Dopamine Receptor Agonists
Same formulary class, not same indication: class membership alone does not establish equivalent uses.